Related references
Note: Only part of the references are listed.Modulatory Effect of Lifestyle-Related, Environmental and Genetic Factors on Paraoxonase-1 Activity: A Review
Dominika Kunachowicz et al.
International Journal of Environmental Research and Public Health (2023)
Paraoxonases at the Heart of Neurological Disorders
Fatimah K. Khalaf et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis
Marco Zuin et al.
DISEASE MARKERS (2022)
Chlorpyrifos oxon crosslinking of amyloid beta 42 peptides is a new route for generation of self-aggregating amyloidogenic oligomers that promote Alzheimer's disease
Seda Onder et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2022)
A critical review on human serum Paraoxonase-1 in the literature: truths and misconceptions
Michael Mackness et al.
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI (2021)
Connection between the Altered HDL Antioxidant and Anti-Inflammatory Properties and the Risk to Develop Alzheimer's Disease: A Narrative Review
Francesca Zimetti et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
Paraoxonase Role in Human Neurodegenerative Diseases
Cadiele Oliana Reichert et al.
ANTIOXIDANTS (2021)
Paraoxonase-1 and-3 Protein Expression in the Brain of the Tg2576 Mouse Model of Alzheimer's Disease
Jose Gregorio Salazar et al.
ANTIOXIDANTS (2021)
Myeloperoxidase-induced modification of HDL by isolevuglandins inhibits paraoxonase-1 activity
Geetika Aggarwal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
The Amyloid-β Pathway in Alzheimer's Disease
Harald Hampel et al.
MOLECULAR PSYCHIATRY (2021)
Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer's Disease and Vascular Dementia
Arianna Romani et al.
ANTIOXIDANTS (2020)
Cladribine Treatment Improved Homocysteine Metabolism and Increased Total Serum Antioxidant Activity in Secondary Progressive Multiple Sclerosis Patients
Anna Jamroz-Wisniewska et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Air Pollution and Alzheimer's Disease: A Systematic Review and Meta-Analysis
Pengfei Fu et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
HDL Proteome and Alzheimer's Disease: Evidence of a Link
Judit Marsillach et al.
ANTIOXIDANTS (2020)
Serum HDL Associated Antioxidant Activity in Alzheimer's Disease: Paraoxonase1 and Dysfunctional HDL
Figen Varlibas et al.
CLINICAL LABORATORY (2020)
Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development
Carlo Cervellati et al.
MINERVA MEDICA (2019)
Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage
Carlo Cervellati et al.
ATHEROSCLEROSIS (2019)
Enzymatic detoxification of organophosphorus pesticides and related toxicants
Karla Alejo-Gonzalez et al.
JOURNAL OF PESTICIDE SCIENCE (2018)
The link of organophosphorus pesticides with neurodegenerative and neurodevelopmental diseases based on evidence and mechanisms
Sara Mostafalou et al.
TOXICOLOGY (2018)
Blood-Brain Barrier Cellular Responses Toward Organophosphates: Natural Compensatory Processes and Exogenous Interventions to Rescue Barrier Properties
Orly Ravid et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevance
Nelusha Shunmoogam et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2018)
A Meta-Analysis on the Relationship of the PON Genes and Alzheimer Disease
Yi Nie et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2017)
Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease
Reisuke H. Takahashi et al.
PATHOLOGY INTERNATIONAL (2017)
Transcriptional regulation of human Paraoxonase 1 by nuclear receptors
N. Ponce-Ruiz et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Serum paraoxonase-1 activity and risk of incident cardiovascular disease: The PREVEND study and meta-analysis of prospective population studies
Setor K. Kunutsor et al.
ATHEROSCLEROSIS (2016)
The relationship between serum paraoxonase levels and carotid atherosclerotic plaque formation in Alzheimer's patients
Ayse Arslan et al.
NEUROLOGIA I NEUROCHIRURGIA POLSKA (2016)
Paraoxonase-1 and Early-Life Environmental Exposures
Judit Marsillach et al.
ANNALS OF GLOBAL HEALTH (2016)
Role of Environmental Contaminants in the Etiology of Alzheimer's Disease: A Review
Manivannan Yegambaram et al.
CURRENT ALZHEIMER RESEARCH (2015)
Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles
Mike Mackness et al.
GENE (2015)
Neuroinflammation in Alzheimer's disease
Michael T. Heneka et al.
LANCET NEUROLOGY (2015)
Common Pesticide, Dichlorodiphenyltrichloroethane (DDT), Increases Amyloid-β Levels by Impairing the Function of ABCA1 and IDE: Implication for Alzheimer's Disease
Gongbo Li et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1
Tiziana Bacchetti et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Is Alzheimer's disease a systemic disease?
Jill K. Morris et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Serum paraoxonase 1 (PON1) measurement: an update
Jose J. Ceron et al.
BMC VETERINARY RESEARCH (2014)
Paraoxonase 1 in neurological disorders
Teresita Menini et al.
REDOX REPORT (2014)
Functional paraoxonase 1 variants modify the risk of Parkinson's disease due to organophosphate exposure
Pei-Chen Lee et al.
ENVIRONMENT INTERNATIONAL (2013)
Household organophosphorus pesticide use and Parkinson's disease
Shilpa Narayan et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2013)
Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex
Ying Huang et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Urinary 8-hydroxy-2′-deoxyguanosine level and plasma paraoxonase 1 activity with Alzheimer's disease
Oguzhan Zengi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2012)
Lack of an association between Paraoxonase 1 gene polymorphisms (Q192R, L55M) and Alzheimer's disease: A meta-analysis
Yan Pi et al.
NEUROSCIENCE LETTERS (2012)
Lack of association between paraoxonase 1 Q192R polymorphism and multiple sclerosis in relapse phase: A case-control study
Ali Moghtaderi et al.
CLINICAL BIOCHEMISTRY (2011)
Alzheimer's Disease: The Challenge of the Second Century
David M. Holtzman et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders
Martha R. Herbert
CURRENT OPINION IN NEUROLOGY (2010)
The paraoxonases: role in human diseases and methodological difficulties in measurement
Jordi Camps et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2009)
Involvement of paraoxonase 1 genetic variants in Alzheimer's disease neuropathology
Valerie Leduc et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity
G Ferretti et al.
MULTIPLE SCLEROSIS JOURNAL (2005)
Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities
DI Draganov et al.
JOURNAL OF LIPID RESEARCH (2005)
Modulation of paraoxonase (PON1) activity
LG Costa et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep
B Mackness et al.
PHARMACOGENETICS (2003)
Share Paper
